SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-20-008587
Filing Date
2020-05-14
Accepted
2020-05-14 07:25:54
Documents
30
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 299358
  Complete submission text file 0001493152-20-008587.txt   1157746

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE vblt-20200331.xml EX-101.INS 77454
3 XBRL SCHEMA FILE vblt-20200331.xsd EX-101.SCH 27336
4 XBRL CALCULATION FILE vblt-20200331_cal.xml EX-101.CAL 38067
5 XBRL DEFINITION FILE vblt-20200331_def.xml EX-101.DEF 33901
6 XBRL LABEL FILE vblt-20200331_lab.xml EX-101.LAB 159323
7 XBRL PRESENTATION FILE vblt-20200331_pre.xml EX-101.PRE 89544
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 20875284
SIC: 2834 Pharmaceutical Preparations